Talk:Immunoglobulin therapy

This is the talk page for discussing improvements to the Immunoglobulin therapy article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Immunoglobulin therapy.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Repeated additions of passive immunity as the mechanism of action

This edit, like another recent one that I reverted, seems to conflate immunoglobulin therapy with passive immunity. While passive immunity is one of the potential benefits of immunoglobulin therapy, as noted in the "Medical Uses" section there are other effects and indications - so the language strongly tying this therapy with passive immunity is incorrect and inconsistent with the body of the article (something that the lede should not do). I'm not sure the article needs to say more about passive immunization than it already does, based on reliable sources. — soupvector (talk) 04:13, 25 December 2015 (UTC)[reply]

I've added a sentence to the lede - hope it helps address the perceived gap. — soupvector (talk) 04:18, 25 December 2015 (UTC)[reply]

Anaphylaxis

Role of IgA disputed doi:10.1111/trf.12796 JFW | T@lk 13:14, 16 August 2019 (UTC)[reply]

Split

The general idea of Immunoglobulin therapy is not limited to the injection of normal human Immunoglobulin. NHIG should be split out as a drug article, so the Ig therapy page can discuss different preparations of Igs used on humans, including the proposed merge from Hyperimmune globulin (Talk:Hyperimmune_globulin#Merger_discussion). --Artoria 2e5 🌉 13:24, 16 December 2020 (UTC)[reply]